You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection: A Randomized Controlled Trial
|
---|---|
Published in |
JAMA: Journal of the American Medical Association, September 2010
|
DOI | 10.1001/jama.2010.1275 |
Pubmed ID | |
Authors |
John P. Neoptolemos, Deborah D. Stocken, Claudio Bassi, Paula Ghaneh, David Cunningham, David Goldstein, Robert Padbury, Malcolm J. Moore, Steven Gallinger, Christophe Mariette, Moritz N. Wente, Jakob R. Izbicki, Helmut Friess, Markus M. Lerch, Christos Dervenis, Attila Oláh, Giovanni Butturini, Ryuichiro Doi, Pehr A. Lind, David Smith, Juan W. Valle, Daniel H. Palmer, John A. Buckels, Joyce Thompson, Colin J. McKay, Charlotte L. Rawcliffe, Markus W. Büchler, for the European Study Group for Pancreatic Cancer |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Germany | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 524 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 6 | 1% |
United Kingdom | 3 | <1% |
Germany | 2 | <1% |
Brazil | 2 | <1% |
France | 2 | <1% |
Australia | 1 | <1% |
Croatia | 1 | <1% |
Unknown | 507 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 79 | 15% |
Student > Ph. D. Student | 60 | 11% |
Other | 58 | 11% |
Student > Doctoral Student | 47 | 9% |
Student > Master | 45 | 9% |
Other | 122 | 23% |
Unknown | 113 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 265 | 51% |
Biochemistry, Genetics and Molecular Biology | 45 | 9% |
Agricultural and Biological Sciences | 32 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 12 | 2% |
Engineering | 8 | 2% |
Other | 33 | 6% |
Unknown | 129 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 December 2021.
All research outputs
#1,976,436
of 25,837,817 outputs
Outputs from JAMA: Journal of the American Medical Association
#12,387
of 36,763 outputs
Outputs of similar age
#7,009
of 108,766 outputs
Outputs of similar age from JAMA: Journal of the American Medical Association
#43
of 141 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 36,763 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 72.7. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 108,766 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 141 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.